New GLP1R insights may lead to better diabetes therapies

Glucagon-like peptide-1 receptor (GLP1R) has been more extensively characterised using advanced imaging techniques, which may aid in the development of better diabetes therapies, according to a study published in Nature Communications.

Medical News Today

Subscribe to our email alerts